129 related articles for article (PubMed ID: 16178910)
1. CD2+ acute promyelocytic leukemia is associated with leukocytosis, variant morphology and poorer prognosis.
Kaito K; Katayama T; Masuoka H; Nishiwaki K; Sano K; Sekiguchi N; Hagino T; Kobayashi M
Clin Lab Haematol; 2005 Oct; 27(5):307-11. PubMed ID: 16178910
[TBL] [Abstract][Full Text] [Related]
2. CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform.
Foley R; Soamboonsrup P; Carter RF; Benger A; Meyer R; Walker I; Wan Y; Patterson W; Orzel A; Sunisloe L; Leber B; Neame PB
Am J Hematol; 2001 May; 67(1):34-41. PubMed ID: 11279655
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis.
Lin P; Hao S; Medeiros LJ; Estey EH; Pierce SA; Wang X; Glassman AB; Bueso-Ramos C; Huh YO
Am J Clin Pathol; 2004 Mar; 121(3):402-7. PubMed ID: 15023045
[TBL] [Abstract][Full Text] [Related]
4. The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes.
Albano F; Mestice A; Pannunzio A; Lanza F; Martino B; Pastore D; Ferrara F; Carluccio P; Nobile F; Castoldi G; Liso V; Specchia G
Haematologica; 2006 Mar; 91(3):311-6. PubMed ID: 16531253
[TBL] [Abstract][Full Text] [Related]
5. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
[TBL] [Abstract][Full Text] [Related]
6. CD34 expression is associated with poor clinical outcome in patients with acute promyelocytic leukemia.
Lee JJ; Cho D; Chung IJ; Cho SH; Park KS; Park MR; Ryang DW; Kim HJ
Am J Hematol; 2003 Jul; 73(3):149-53. PubMed ID: 12827650
[TBL] [Abstract][Full Text] [Related]
7. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
Oelschlaegel U; Mohr B; Schaich M; Schäkel U; Kroschinsky F; Illmer T; Ehninger G; Thiede C
Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801
[TBL] [Abstract][Full Text] [Related]
8. The T-lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells.
Grimwade D; Outram SV; Flora R; Ings SJ; Pizzey AR; Morilla R; Craddock CF; Linch DC; Solomon E
Cancer Res; 2002 Aug; 62(16):4730-5. PubMed ID: 12183432
[TBL] [Abstract][Full Text] [Related]
9. Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyelocytic leukemia cells.
Breccia M; De Propris MS; Stefanizzi C; Raponi S; Molica M; Colafigli G; Minotti C; Latagliata R; Diverio D; Guarini A; Foà R
Ann Hematol; 2014 Nov; 93(11):1819-23. PubMed ID: 24912771
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of acute promyelocytic leukemia in Czechia: results and analysis of prognostic factors].
Schwarz J; Korístek Z; Starý J; Zák P; Kozák T; Marková J; Michalová K; Dvoráková D; Mayer J; Cetkovský P
Vnitr Lek; 2008; 54(7-8):757-70. PubMed ID: 18780575
[TBL] [Abstract][Full Text] [Related]
11. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
12. Secondary acute promyelocytic leukemia. Characteristics and prognosis of 14 patients from a single institution.
Pollicardo N; O'Brien S; Estey EH; al-Bitar M; Pierce S; Keating M; Kantarjian HM
Leukemia; 1996 Jan; 10(1):27-31. PubMed ID: 8558933
[TBL] [Abstract][Full Text] [Related]
13. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center.
Xin L; Wan-jun S; Zeng-jun L; Yao-zhong Z; Yun-tao L; Yan L; Chang-chun W; Qiao-chuan L; Ren-chi Y; Ming-zhe H; Jian-xiang W; Lu-gui Q
Leuk Res; 2007 Jun; 31(6):765-71. PubMed ID: 17007927
[TBL] [Abstract][Full Text] [Related]
14. The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): does it prove true for the M3-variant?
Exner M; Thalhammer R; Kapiotis S; Mitterbauer G; Knöbl P; Haas OA; Jäger U; Schwarzinger I
Cytometry; 2000 Apr; 42(2):106-9. PubMed ID: 10797447
[TBL] [Abstract][Full Text] [Related]
15. [The clinical and laboratory features of acute promyelocytic leukemia: an analysis of 513 cases].
Liang JY; Wu DP; Liu YJ; Ma QF; Gong JX; Zhu MQ; Xue YQ; Chen ZX
Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):389-92. PubMed ID: 18953948
[TBL] [Abstract][Full Text] [Related]
16. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
Xu XJ; Shi SW; Tang YM; Song H; Yang SL; Wei J; Xu WQ; Pan BH; Chen YH; Zhao FY; Shen HQ; Qian BQ; Zhang LY; Ning BT
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival rates.
Yanada M; Jinnai I; Takeuchi J; Ueda T; Miyawaki S; Tsuzuki M; Hatta Y; Usui N; Wada H; Morii T; Matsuda M; Kiyoi H; Okada M; Honda S; Miyazaki Y; Ohno R; Naoe T
Leuk Res; 2007 Jul; 31(7):907-14. PubMed ID: 17005250
[TBL] [Abstract][Full Text] [Related]
18. CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?
Murray CK; Estey E; Paietta E; Howard RS; Edenfield WJ; Pierce S; Mann KP; Bolan C; Byrd JC
J Clin Oncol; 1999 Jan; 17(1):293-7. PubMed ID: 10458245
[TBL] [Abstract][Full Text] [Related]
19. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome.
Yanada M; Matsushita T; Asou N; Kishimoto Y; Tsuzuki M; Maeda Y; Horikawa K; Okada M; Ohtake S; Yagasaki F; Matsumoto T; Kimura Y; Shinagawa K; Iwanaga M; Miyazaki Y; Ohno R; Naoe T
Eur J Haematol; 2007 Mar; 78(3):213-9. PubMed ID: 17241371
[TBL] [Abstract][Full Text] [Related]
20. Acute promyelocytic leukemia: morphological and clinical features.
Invernizzi R; Iannone AM; Bernuzzi S; D'Alessio A; Fiamenghi C; Ippoliti G; Scagliosi S; Ascari E
Haematologica; 1993; 78(3):156-61. PubMed ID: 8375744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
